SCHEMBL22100992

SCHEMBL22100992

O[C@H]1CCCC2(C1)OCCO2

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30291451 1.00 TSHR (0.33) TSHR
SCHEMBL1338928 0.86 KDM4E (0.31)
SCHEMBL5326358 0.83
SCHEMBL19309616 0.82 TSHR (0.46) TSHR
SCHEMBL20859051 0.79 TSHR (0.48) TSHR
SCHEMBL22995757 0.77 TSHR (0.46) TSHR
SCHEMBL16985345 0.75
SCHEMBL20869261 0.74 TSHR (0.42) TSHR
SCHEMBL337849 0.74 APLNR (0.33)
SCHEMBL12886442 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3738954-A1 METHOD OF PREPARATION OF SUBSTITUTED 2,4-DIAMINO-PYRIMIDINE-5-CARBOXAMIDES Signal Pharmaceuticals, LLC (US) 2020-11-18 EP disclosed
EP-3099302-B1 CRYSTALLINE FORMS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE SIGNAL PHARM LLC (US) 2020-06-17 EP disclosed